Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 5/20 | 0.57 |
| ▸ | DHCR7 | Q9UBM7 | 5/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 10/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7925677 | 0.81 | EBP (0.61) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL22032774 | 0.81 | ALDH1A1 (0.62) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL22032742 | 0.78 | ALDH1A1 (0.63) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL5963420 | 0.76 | EPHX2 (0.60) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL10019221 | 0.75 | EPHX2 (0.64) | EBPDHCR7EPHX2 | |
| SCHEMBL22033930 | 0.75 | EBP (0.67) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL31212435 | 0.75 | EBP (0.70) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL31212431 | 0.75 | EBP (0.70) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL22032760 | 0.75 | EBP (0.61) | EBPDHCR7NPSR1EPHX2ALDH1A1 | |
| SCHEMBL20306068 | 0.75 | EBP (0.61) | EBPDHCR7NPSR1EPHX2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105873913-A | Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins | 得克萨斯系统大学评议会 | 2016-08-17 | — | — | CN | disclosed |